LSQ and NZBIO sign MoU
14 May, 2014Life Sciences Queensland Limited (LSQ) recently recognised its ongoing interaction with NZBIO with the signing of a memorandum of understanding (MoU).
AXT and Delmic sign distribution agreement
14 May, 2014Scientific equipment supplier AXT has signed an exclusive distribution agreement with Delmic, a Dutch company specialising in fluorescent/SEM (SECOM) and cathodoluminescent/SEM (SPARC) correlative microscopy technology.
Australia's scientists react to the Budget
14 May, 2014 by Lauren DavisThe 2014-15 Budget will affect several areas of science, provoking comments from experts involved in the industry.
$42 million for tropical health and medicine research
12 May, 2014The federal government has announced $42 million for tropical health and medicine research to be conducted at the Australian Institute of Tropical Health and Medicine (AITHM), based at James Cook University (JCU).
Orthocell acquires IP and a new chairman
12 May, 2014Regenerative medicine company Orthocell has acquired key pieces of intellectual property (IP) from its research partners at The University of Western Australia (UWA). The company has also welcomed the appointment of Dr Stewart Washer to its board as chairman.
Qiagen products cleared by FDA
08 May, 2014The US FDA has cleared the Qiagen artus C. difficile QS-RGQ MDx Kit to qualitatively detect Clostridium difficile, a widespread healthcare-associated infection. The test was developed in partnership with IntelligentMDx and CE marked in December 2013.
New CSIRO lab and board member
08 May, 2014CSIRO and Deakin University have officially opened the new Biosecure Immunology Laboratory. CSIRO has also announced the appointment of biotechnologist Dr Peter Riddles as a part-time member of the organisation's board.
First international guests announced for NZ Scifest
05 May, 2014This year's New Zealand International Science Festival (Scifest) will be held in Dunedin from 5-13 July. The aim of the event is to promote and celebrate science, technology and the natural environment to a wide general audience, showing that science is exciting, fun and accessible.
Honey researcher receives USC Chancellor's Medal
29 April, 2014Environmental scientist Daniel Meloncelli has been awarded a University of the Sunshine Coast (USC) Chancellor's Medal. It was one of only three Chancellor's Medals presented at USC's recent graduation ceremonies, awarded to outstanding graduates who have contributed to the university or wider community and achieved a high academic level during their studies.
Lonza certification and committee changes
29 April, 2014Lonza Bioscience Singapore has received cGMP certification from the Singapore Health Sciences Authority (HSA) for its cell-therapy manufacturing facility, while Lonza Group has announced changes in the composition of its executive committee (EC).
US excipients market forecast to rise
28 April, 2014US research firm The Freedonia Group has released the report 'Excipients', an industry study showcasing trends and forecasts in the pharmaceutical excipients market. The study also analyses market environment factors, evaluates company market share and profiles 47 US industry competitors.
Coastal research centre for China and New Zealand
23 April, 2014The University of Waikato has signed an agreement with the Yantai Institute of Coastal Zone Research, Chinese Academy of Sciences, to establish a coastal biotechnology research centre. With bases in both Tauranga and China, the China-New Zealand Coastal Biotechnology Joint Research Centre would aim to integrate China and New Zealand's coastal biotechnology research experts.
CSIRO bracing for cuts, claims Fairfax
16 April, 2014 by Lauren DavisFairfax Media has published an article claiming that science body CSIRO is bracing for a May budget cut of up to $150 million, or more than 20% of its total government funding, with the organisation's top executive team modelling a range of scenarios based around this outcome.
Merck Millipore announces incoming CEO and president
15 April, 2014Merck Millipore, the life science division of Merck, has announced the appointment of Dr Udit Batra as its incoming president and CEO. Dr Batra comes to Merck Millipore from the consumer health division of Merck KGaA, where he successfully grew the business in established and emerging markets.
Qiagen acquires biomarker for blood disorders
14 April, 2014Qiagen has acquired an exclusive worldwide licence to the biomarker calreticulin (CALR), whose mutations are found in an estimated 15% of cases of myeloproliferative neoplasms (MPNs) - a group of blood disorders involving overproduction of blood cells.
